Person:
TANRIVERDİ, MÜBERRA

Loading...
Profile Picture
Status
Organizational Units
Job Title
First Name
MÜBERRA
Last Name
TANRIVERDİ
Name
Email Address
Birth Date

Search Results

Now showing 1 - 5 of 5
  • PublicationMetadata only
    Cancer-Related Fatigue and Daily Living Activities in Pediatric Cancer Survivors
    (2022-11-01) Tanrıverdi M.; Çakır F. B.; TANRIVERDİ, MÜBERRA; ÇAKIR, FATMA BETÜL
  • PublicationMetadata only
    Yutma fonksiyon bozuklukları, gastroözofageal reflü ve solunum yolu hastalıkları.
    (2022-01-01) Tanrıverdi M.; Çollak A.; Doğan G.; TANRIVERDİ, MÜBERRA; ÇOLLAK, ABDULHAMİT; DOĞAN, GÜZİDE
    Yutma fonksiyon bozuklukları konjenital hastalıklara, edinilmiş nörolojik veya anatomik problemlere sekonder olarak gelişebilir. Solunum ve yutma arasındaki hassas senkronizasyon, hava yolunu korumak ve aspirasyonu önlemek için gereklidir. Videofloroskopik yutma çalışması gibi aletsel testler pediatrik disfajinin değerlendirilmesinde ve yönetiminde önemli bir rol oynamaktadır. Oral-faringeal disfajisi olan hastalarda hava yolu korumasında bir gecikme, laringeal penetrasyon ve/veya trakeal as pirasyonun varlığı veya yokluğu ile tanımlanır. Aspirasyon tekrarlayan akciğer enfeksiyonlarına zemin hazırlamaktadır. Çocuklarda gastroözofageal reflü hastalığı (GÖRH) ile astım, kronik öksürük, tekrarlayan pnömoni gibi hastalıklar birlikte görülebilmektedir. Kronikleşmiş ve tedaviye dirençli solunum yolu bulgularına sahip hastalarda GÖRH’nin varlığı mutlaka araştırılmalıdır. GÖRH’de asidik reflü yanında, zayıf asidik ve asit olmayan reflü de solunum yolu hastalıklarıyla ilişkilidir. Reflü için tipik yakınma ve bulgulara sahip olmayan hastalarda ise ampirik tedavilerden kaçınılmalıdır. Yutma fonksiyon bozuklukları ve GÖRH enfeksiyon dışı alt hava yolu hastalıkları için risk faktörleridir.
  • PublicationMetadata only
    Investigation of lifestyle behaviors of women with and without stress urinary incontinence
    (2020-09-01) Ciftcioglu G. G.; Tunali A. N.; TANRIVERDİ M.; TANRIVERDİ, MÜBERRA
    Aim: The aim of this study was to compare the lifestyle behaviors of women with and without stress urinary incontinence (SUI), and to investigate the effects of lifestyle behaviors on SUI. Materials and Methods: The study included 30 women who were diagnosed with SUI, 25-50 years old, who agreed to participate in the study voluntarily and 30 healthy women who met our study criteria with a total of 60 women. The data were evaluated using a questionnaire including demographic information and urinary incontinence risk factors of the women prepared by the researcher, and healthy lifestyle behaviors by Healthy Lifestyle Behavior Scale-II (HLBS-II), SUI by International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Results: When the HLBS-II scores of the groups were examined, it was observed that the scores of the group with SUI were lower and a statistically significant difference was found between the groups (p<0.005). There was a negative statistically significant relationship between the total score HLBS-II and total score ICIQ-SF (p=0.026). Discussion: As a result, healthy lifestyle behaviors are associated with SUI, and will affect the lifestyle positively.
  • PublicationMetadata only
    Reliability and Validity of the Turkish Translation of the PedsQL™ 3.0 Neuromuscular Module for 2-to 4-Year-Olds in Spinal Muscular Atrophy.
    (2024-04-08) Kutlutürk Yikilmaz S.; TANRIVERDİ M.; OKTEM S.; TANRIVERDİ, MÜBERRA
    Background: The Pediatric Quality of Life InventoryTM Neuromuscular Module (PedsQLTM 3.0 NM) evaluates the health-related quality of life in children who are affected by neuromuscular diseases. This study’s aim is to assess the adaptation of the PedsQLTM 3.0 NM Turkish version (PedsQLTM 3.0 NM-TR) for 2-4 years old in spinal muscular atrophy (SMA). Methods: The procedure of translating the PedsQLTM 3.0 NM into Turkish was conducted in accordance with the translation methodology outlined by the PedsQLTM measurement model. The PedsQLTM 3.0 NM-TR was administered to 54 parents of children with SMA aged 2-4 years. The test-retest reliability and intraclass correlation coefficient (ICC) were measured for reliability analysis. Cronbach\"s alpha coefficient and item score correlations were calculated for internal consistency. Concurrent construct validity was evaluated by Pearson correlations between the outcomes of the PedsQLTM 4.0 Generic Core Scale (PedsQLTM 4.0 GCS) and the PedsQLTM 3.0 NM. Results: The PedsQLTM 3.0 NM-TR total score shows excellent reliability. The Cronbach\"s alpha values for the PedsQLTM 3.0 NM ranged between 0.871-0.906, while those for the PedsQLTM 4.0 GCS ranged 0.843-0.897. Test-retest ICC values for the PedsQLTM 3.0 NM-TR ranged 0.812-0.917, and for the PedsQLTM 4.0 GCS ranged 0.773-0.899. The relationship between the PedsQLTM 3.0 NM-TR and the subscores of the PedsQLTM 4.0 GCS demonstrated a range of correlations from excellent to fair, indicating the interplay between two scales. Conclusions: This study established the PedsQLTM 3.0 NM-TR as reliable, valid, and feasible for use in children aged 2-4 years old with SMA.